Advanced Biopsy Technologies Transform the Global Cancer Diagnostics Landscape
The global cancer biopsy market was valued at US$ 24.7 Bn in 2022 and is projected to grow at a CAGR of 11.4% from 2023 to 2031, reaching more than US$ 66.0 Bn by 2031. The market is witnessing strong growth as cancer incidence continues to rise worldwide and healthcare providers increasingly adopt advanced diagnostic technologies. Growing Cancer Burden Fuels Market Expansion The increasing...
0 Comments 0 Shares 10 Views 0 Reviews